IMARC Group, a leading market research company, has recently releases report titled “Pneumonia Testing Market Report by Type (Analyzers, Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology (Enzyme-linked Immunosorbent Assay, Immunofluorescence, Western Blot, Polymerase Chain Reaction, Immunohistochemistry, and Others), End User (Hospitals, Diagnostic Laboratories, Homecare, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the market.

How Big is the Pneumonia Testing Market?

The global pneumonia testing market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Industry Overview of Pneumonia Testing

Pneumonia is a respiratory infection affecting the lower part of the respiratory system and is caused by various microorganisms such as bacteria, viruses, and fungi. It spreads through the inhalation of droplets released into the air when an infected individual sneezes or coughs. This condition results in inflammation of the lung's air sacs, leading to breathing difficulties. Common symptoms include reduced appetite, low-grade fever, dry cough, headaches, fatigue, chills, and chest discomfort. Pneumonia can be diagnosed by conducting several tests such as a physical examination, review of medical history, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and analysis of fluid samples.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/pneumonia-testing-market/requestsample

What are the growth prospects and trends in the pneumonia testing industry?

Currently, there is a growing trend in the use of point of care (POC) testing for pneumonia detection due to its higher efficiency and ability to provide accurate results. This is a significant driving factor in the market, particularly with the expanding healthcare industry. Additionally, the market is experiencing growth due to the introduction of advanced tests such as immunochromatographic and pneumococcal urinary antigen (UAT) tests.

The global awareness about the advantages of early diagnosis is also contributing to increased pneumonia testing worldwide. Governments of various countries are increasing healthcare expenditure, further boosting the market growth. Moreover, the adoption of enzyme-linked immunosorbent assay for pneumonia detection is on the rise because of its high sensitivity and ease of use.

The market is further stimulated by factors such as the growing elderly population and the increasing prevalence of pneumonia in children. Key market players are actively launching new products and obtaining approvals, which is expected to strengthen market growth.

Leading Companies Operating in the Global Pneumonia Testing Industry:

• Abbott Laboratories
• Becton
• Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories Inc
• Curetis GmbH (OpGen)
• DiaSorin S.p.A.
• Hologic Inc
• Meridian Bioscience Inc
• Quest Diagnostics Incorporated
• Quidel Corporation
• Roche Holding AG
• Thermo Fisher Scientific Inc.

Pneumonia Testing Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Type:

• Analyzers
• Consumables

Breakup by Method:

• Immunodiagnostics
• Molecular Diagnostics
• Point of Care Testing

Breakup by Technology:

• Enzyme-linked Immunosorbent Assay
• Immunofluorescence
• Western Blot
• Polymerase Chain Reaction
• Immunohistochemistry
• Others

Breakup by End User:

• Hospitals
• Diagnostic Laboratories
• Homecare
• Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163